Malaria: A molecular marker of artemisinin resistance

The Lancet

Volumn 383, Issue 9927, 2014, Pages 1439-1440

  White, Nicholas J ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ DERIVATIVE; ARTESUNATE; MOLECULAR MARKER; PYRIMETHAMINE PLUS SULFADOXINE; ARTEMISININ; CHLOROQUINE;

CHROMOSOME 13; GENETIC ASSOCIATION; HUMAN; IN VITRO STUDY; MALARIA; MALARIA FALCIPARUM; NONHUMAN; NOTE; PARASITE CLEARANCE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM; ANTIMALARIAL DRUG RESISTANCE; ANTIMALARIAL DRUG SUSCEPTIBILITY; CAMBODIA; PARASITE ISOLATION;

ANTIMALARIALS; ARTEMISININS; DRUG RESISTANCE; HUMANS; MALARIA;

EID: 84899536207     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)60656-5     Document Type: Note

References (12)

1. WHO. World Malaria Report 2013. Geneva: World Health Organization, 2013. http://www.who.int/malaria/publications/world-malaria-report-2013/en/ (accessed April 1, 2014).
2. Noedl H, Se Y, Schaecher K., Smith BL, Socheat D, Fukuda MM, for the Artemisinin Resistance in Cambodia 1 (ARC1) Study Consortium. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 2008; 359: 2619-20.
3. Dondorp AM, Nosten F, Yi P., et al Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009; 361: 455-67.
4. Carrara VI, Lwin KM, Phyo A.P., et al Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study. PLoS Med 2013; 10: e1001398.
5. Kyaw MP, Nyunt MH, Chit K, et al Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar. PLoS One 2013; 8: e57689.
6. WHO. Status report on artemisinin resistance. January, 2014. http://www.who.int/malaria/publications/atoz/status-rep-artemisinin-resistance- jan2014.pdf (accessed April 1, 2014).
7. Flegg JA, Guerin PJ, White N.J., Stepniewska K. Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar J 2011; 10: 339.
8. Witkowski B, Amaratunga C, Khim N., et al Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. Lancet Infect Dis 2013; 13: 1043-49.
9. Ariey F, Witkowski B, Amaratunga C., et al A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 2014; 505: 50-55.
10. Cheeseman IH, Miller BA, Nair S, et al A major genome region underlying artemisinin resistance in malaria. Science 2012; 336: 79-82.
11. Takala-Harrison S., Clark TG, Jacob C.G., et al Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in southeast Asia. Proc Natl Acad Sci USA 2013; 110: 240-45.
12. Miotto O, Almagro-Garcia J, Manske M., et al Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat Genet 2013; 45: 648-55.